In this episode of Breast Cancer Conversations, host Laura Carfang speaks with Annick Pyfferoen about her experience being diagnosed with de novo metastatic breast cancer and navigating several lines of treatment including targeted therapy, chemotherapy, a clinical trial attempt involving tumor-infiltrating lymphocytes, Enhertu, and Xeloda.

She speaks openly about what it felt like to experience rapid progression and why having a plan, even one that may change, helps her navigate uncertainty.

This episode is a reminder that metastatic breast cancer care is not only about what is happening on scans. It is also about communication, side effect management, informed decision-making, emotional support, and helping people live as well as possible for as long as possible.

Support the show

Listener Feedback

If this episode resonated with you, we invite you to leave a review on Apple Podcasts or Spotify.

You can also click the link in the show notes that says "Love this episode? Send us a text" to share feedback.

Messages are completely anonymous.

If you would like us to follow up directly, please include your email address in your message so we can respond.

Latest News:

Join our Mailing List - New content drops every Monday!
Discover FREE programs, support groups, and resources from SurvivingBReastCancer.org!
Become a Breast Cancer Conversations+ Member! Sign Up Now.
Enjoying our content? Please consider supporting our work.